Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Precision Medicine
Fierce Pharma
McKesson acquires Maryland CRO for $2.25 billion
Healthcare conglomerate McKesson has dropped $2.25 billion for Precision Medicine Group's R&D and commercialization capabilities.
Donavyn Coffey
Aug 25, 2026 11:22am
Fierce Healthcare
Verily banks $300M to fuel AI road map, separates from Alphabet
Mar 19, 2026 6:00pm
Atrium arises from Avidity buyout with $270M, preclinical assets
Feb 27, 2026 11:05am
Amgen weaves in UK biotech with up to $840M acquisition
Jan 6, 2026 10:35am
2 European biotechs link to tackle neurodegenerative diseases
Oct 20, 2025 8:20am
Foundation Medicine awards new grant for biommarker testing push
Oct 6, 2025 8:45am